Fresenius net profit edges up

Fresenius Medical Care's (FMS) Q3 net profit +1.2% to $273M, beating forecasts of $268M, with earnings boosted by higher revenues per treatment in the U.S., the dialysis provider's most important market.

Net revenue +7% to $3.67B vs consensus of $3.65B.

Adjusted EPS +7% to $0.95.

Fresenius expects FY net profit at the lower end of its forecast range of $1.1-1.15B, due to austerity in the U.S. Forecasts that revenue will grow over 6% to more than $14.6B. (PR)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs